Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 4
1986 2
1988 1
1989 2
1990 2
1992 1
1993 3
1994 2
1995 3
1996 4
1997 4
1998 4
1999 5
2000 9
2001 2
2002 3
2003 6
2004 9
2005 13
2006 9
2007 23
2008 28
2009 26
2010 27
2011 29
2012 39
2013 52
2014 53
2015 57
2016 59
2017 60
2018 55
2019 36
2020 43
2021 24
2022 29
2023 18
2024 22
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

688 results

Results by year

Filters applied: . Clear all
Page 1
Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib).
Hussain M, Corcoran C, Sibilla C, Fizazi K, Saad F, Shore N, Sandhu S, Mateo J, Olmos D, Mehra N, Kolinsky MP, Roubaud G, Özgüroǧlu M, Matsubara N, Gedye C, Choi YD, Padua C, Kohlmann A, Huisden R, Elvin JA, Kang J, Adelman CA, Allen A, Poehlein C, de Bono J. Hussain M, et al. Among authors: choi yd. Clin Cancer Res. 2022 Apr 14;28(8):1518-1530. doi: 10.1158/1078-0432.CCR-21-3940. Clin Cancer Res. 2022. PMID: 35091440 Clinical Trial.
Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2, or ATM Alterations Identified by Testing Circulating Tumor DNA.
Matsubara N, de Bono J, Olmos D, Procopio G, Kawakami S, Ürün Y, van Alphen R, Flechon A, Carducci MA, Choi YD, Hotte SJ, Korbenfeld E, Kramer G, Agarwal N, Chi KN, Dearden S, Gresty C, Kang J, Poehlein C, Harrington EA, Hussain M. Matsubara N, et al. Among authors: choi yd. Clin Cancer Res. 2023 Jan 4;29(1):92-99. doi: 10.1158/1078-0432.CCR-21-3577. Clin Cancer Res. 2023. PMID: 36318705 Free PMC article. Clinical Trial.
Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis.
Oya M, Joung JY, Lee JY, Sugimoto M, Choi YD, Hong JH, Uemura H, Nishimura K, Tsumura H, Kawakami S, Hirayama Y, Kwon TG, Kwak C, Suzuki H, Fujita T, Nii M, McGuinness D, Dujka M, Poehlein C, Saad F, Clarke N. Oya M, et al. Among authors: choi yd. Cancer Sci. 2025 Jun;116(6):1638-1647. doi: 10.1111/cas.16459. Epub 2025 Mar 18. Cancer Sci. 2025. PMID: 40099663 Free PMC article. Clinical Trial.
Hybrid granular cell tumor/perineurioma.
Kim SS, Choi YD, Lee JH, Choi C, Park CS. Kim SS, et al. Among authors: choi yd. Korean J Pathol. 2014 Dec;48(6):409-12. doi: 10.4132/KoreanJPathol.2014.48.6.409. Epub 2014 Dec 31. Korean J Pathol. 2014. PMID: 25588629 Free PMC article. No abstract available.
Reply by Authors.
Lee J, Kim HY, Goh HJ, Heo JE, Almujalhem A, Alqahtani AA, Chung DY, Chang K, Choi YD, Rha KH. Lee J, et al. Among authors: choi yd. J Urol. 2020 Jan;203(1):143-144. doi: 10.1097/01.JU.0000605592.46038.ca. Epub 2019 Oct 23. J Urol. 2020. PMID: 31644373 No abstract available.
Methyl jasmonate as a vital substance in plants.
Cheong JJ, Choi YD. Cheong JJ, et al. Among authors: choi yd. Trends Genet. 2003 Jul;19(7):409-13. doi: 10.1016/S0168-9525(03)00138-0. Trends Genet. 2003. PMID: 12850447 Review.
688 results